Editorial Expression of Concern: Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study. [PDF]
Emarh M.
europepmc +1 more source
The Association between Medroxyprogesterone Acetate Exposure and Meningioma. [PDF]
Griffin RL.
europepmc +1 more source
Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women with HIV on efavirenz. [PDF]
Mollan KR +17 more
europepmc +1 more source
The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Qiu J +5 more
europepmc +1 more source
Cervical Secretions from Women After Depot Medroxyprogesterone Acetate (Depo-Provera) Administration Promote HIV Infectivity Ex Vivo. [PDF]
Tasker C, Roche NE, Lo Y, Chang TL.
europepmc +1 more source
A Matched Case-Control Study Examining the Association Between Exposure to Depot Medroxyprogesterone Acetate and Cerebral Meningioma Using an Active Comparator. [PDF]
Griffin R, Arend R.
europepmc +1 more source
Three different protocols for pituitary suppression: progestins (dydrogesterone or medroxyprogesterone acetate) versus GnRH antagonist-balancing efficacy and cost in ovarian stimulation. [PDF]
Özcan P +6 more
europepmc +1 more source
The effect of medroxyprogesterone acetate plus conjugated equine estrogens on lipoprotein(a) and apolipoprotein concentrations in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Han R, Wang Z, Prabahar K, Wan D.
europepmc +1 more source
Cumulative Live Birth Rates in Women Undergoing Progestin-Primed Ovarian Stimulation Using Medroxyprogesterone Acetate, Dydrogesterone, and Progesterone: A Retrospective Analysis. [PDF]
Wu F +5 more
europepmc +1 more source

